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Mitochondrial uncoupling is implicated in many patho(physiological) states. Using confocal live cell imaging and
an optical O2 sensing technique, we show that moderate uncoupling of the mitochondria with plecomacrolide Baf
(bafilomycin A1) causes partial depolarization of the mitochondria and deep sustained deoxygenation of human colon
cancer HCT116 cells subjected to 6% atmospheric O2. A decrease in iO2 (intracellular O2) to 0–10 μM, induced by
Baf, is sufficient for stabilization of HIFs (hypoxia inducible factors) HIF-1α and HIF-2α, coupled with an increased
expression of target genes including GLUT1 (glucose transporter 1), HIF PHD2 (prolyl hydroxylase domain 2) and CAIX
(carbonic anhydrase IX). Under the same hypoxic conditions, treatment with Baf causes neither decrease in iO2 nor
HIF-α stabilization in the low-respiring HCT116 cells deficient in COX (cytochrome c-oxidase). Both cell types display
equal capacities for HIF-α stabilization by hypoxia mimetics DMOG (dimethyloxalylglycine) and CoCl2, thus suggesting
that the effect of Baf under hypoxia is driven mainly by mitochondrial respiration. Altogether, by activating HIF signalling
under moderate hypoxia, mitochondrial uncoupling can play an important regulatory role in colon cancer metabolism
and modulate adaptation of cancer cells to natural hypoxic environments.
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INTRODUCTION
Plecomacrolide Baf (bafilomycin A1) [1], known as a potent in-
hibitor of the V-ATPase (vacuolar H+ -ATPase) [2–4], regulates
a number of metabolic processes associated with translocation of
protons into the acidic compartments. Treatment with Baf causes
lysosome dysfunction, decrease in pH and elevation of cytoso-
lic Ca2 + , and neurotransmission failure in neural cells [5–10],
which, in turn, induces permeability transition pore opening [11]
and cell death. Impaired fusion of autophagosomes with dysfunc-
tional lysosomes inhibits autophagy [12] and triggers apoptosis
[13] and therefore is considered to be one of the main mech-
anisms of the anticancer effect of Baf. In agreement with pro-
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Abbreviations used: AA, antimycin A; Baf, bafilomycin A1; CAIX, carbonic anhydrase IX; CMA, concanamycin A; COX, cytochrome c oxidase; m, membrane potential; DAPI,
4′,6-diamidino-2-phenylindole; DIC, differential interference contrast; DMOG, dimethyloxalylglycine; FIH, factor inhibiting HIF; GLUT1, glucose transporter 1; HIF, hypoxia inducible factor;
HRE, hypoxia response element; HRP, horseradish peroxidase; iO2, intracellular O2; MTG, Mito Tracker® Green; OCR, O2 consumption rate; PDL, poly-D-lysine; PHD, prolyl hydroxylase
domain; RT, reverse transcription; SCO2, synthesis of COX 2; TR-F, time-resolved fluorescence; TMRM, tetramethyl rhodamine methyl ester; UCP, uncoupling protein; V-ATPase, vacuolar
H+ -ATPase; VDAC1, voltage-dependent anion channel 1; VHL, von Hippel–Lindau; WT, wild-type.
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apoptotic properties, Baf and another V-ATPase inhibitor CMA
(concanamycin A) were also shown to induce mitochondrial de-
polarization and apoptosis in leukaemic monocytes by activating
the production of nitric oxide [14].
Anti-cancer effects of Baf connect V-ATPase and HIF-1
(hypoxia inducible factor 1) [15–17]. Baf was shown to pro-
mote direct interaction of V0 subunit c (ATP6V0C) with HIF-
1α and its stabilization, which, in turn, induced p21WAF1/Cip1-
mediated growth arrest in a number of cancer cell lines [15–
17]. ATP6V0C protects HIF-1α from interaction with VHL (von
Hippel–Lindau) E3 ubiquitin ligase and subsequent proteasomal
degradation. In normoxia HIF-α subunits are maintained at low
levels. Upon hydroxylation by O2-dependent prolyl and aspar-
aginyl hydroxylases [PHD (prolyl hydroxylase domain) 1–4 and
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FIH (factor inhibiting HIF)], HIF-α subunits undergo degradation
through VHL protein or lose their DNA binding capacity [18].
The rate of HIF-α degradation decreases at low O2 (hypoxia) and
α-ketoglutarate availability, or upon pharmacological inhibition
of PHDs [19].
Identifying new molecules targeting HIFs is of high practical
interest, because HIFs regulate cancer cell metabolism and tu-
mour progression [20]. The majority of therapeutic compounds
targeting cancer via HIF signalling have an inhibitory effect on
HIF stabilization/transactivation (see [21]). However, the results
on Baf-dependent cancer suppression mediated by HIF-1 contra-
dict the role of HIF-1α as a transcriptional regulator of cancer
cell survival and progression of many tumours [20], including
colon cancer [22–24]. In solid tumours, deep deoxygenation [25]
contributes to HIF-1α stabilization, the latter promotes cancer de-
velopment through VEGF (vascular endothelial growth factor)-
dependent vascularization and pro-glycolytic rearrangement of
cell metabolism [20]. Surprisingly, expression of common HIF-1
targeted genes was not affected by Baf [17].
Despite the remarkable effect of Baf on HIF-1α, stabilization
of HIF-2α and its role in Baf-dependent cancer suppression has
not been analysed. Yet, the unique transcriptional signatures of
HIF-1 and HIF-2 make them very specific regulators of tumour
progression. Thus, HIF-2 is associated with malignant tumours
and poor survival prognosis [26–29], while accumulation of HIF-
1α in a number of HIF-2-associated tumours was linked to de-
creased patient mortality [30,31].
The recently found uncoupling effect of Baf on isolated mi-
tochondria [32] and neuronal cells [33] may also contribute to
stabilization of HIF-α subunits by activating respiration and de-
creasing iO2 (intracellular O2) levels. Indeed, it is known that
increased mitochondrial activity regulates HIF-α stabilization in
an iO2-dependent manner [34–37]. Knowing that relative oxy-
genation of respiring cells decreases at reduced O2 availability
[38], we hypothesized that at physiological O2 levels (2–12 %
O2), treatment with Baf can shift cell deoxygenation to levels
sufficient for HIF-1α and HIF-2α stabilization. To check this,
we compared the effect of Baf on HIF signalling in two human
colon cancer cell lines, exposed to 6 % O2 for 5 h. As models we
used actively respiring WT (wild-type) HCT116 cells and low
respiring HCT116 cells deficient in SCO2 protein (synthesis of




iO2 sensitive probe NanO2 [40] was from Luxcel Biosciences.
OptiMEM I medium, TMRM (tetramethyl rhodamine methyl es-
ter), MTG (Mito Tracker® Green) FM, DAPI (4′,6-diamidino-
2-phenylindole), Fluo-4 AM and ProLong® Gold were from
Invitrogen Life Technologies. Amersham ECLTM Prime West-
ern blotting reagent was from GE Healthcare Life Sciences;
pre-made acrylamide gels, running and transfer buffer were
from GenScript; BCATM Protein Assay kit was from Thermo
Fisher Scientific; protease inhibitor mixture tablets were from
Roche Applied Sciences; CellTiter-Glo® ATP Assay, ImProm-
IITM RT (reverse transcription) System and PCR Master Mix
were from Promega. SafeView DNA stain was from NBS Bio-
logicals. Primary antibodies were against: α-tubulin (T5168,
Sigma), HIF-1α and HIF-2α (MAB1536 and AF2886, R&D
Systems), HIF-1α (NB100-105, Novus Biologicals), HIF-1β
(ab2771, Abcam), HIF PHD2 (4835, Cell Signalling Techno-
logy), HRP (horseradish peroxidase)-conjugated mouse anti-
goat, mouse anti-rabbit and donkey anti-mouse IgG (A9452,
A1949 and A0168, Sigma). Baf, CMA, DMOG (dimethyl-
oxalylglycine), DEPC (diethyl pyrocarbonate), collagen IV,
FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone)
and other reagents were from Sigma–Aldrich. Primers were
designed using Primer-BLAST program (http://www.ncbi.
nlm.nih.gov/tools/primer-blast/) (Supplementary Table S1 at
http://www.bioscirep.org/bsr/032/bsr0320587add.htm) and were
synthesized by Sigma–Aldrich. Plasticware was from Sarstedt,
Corning Life Sciences (Corning), Ibidi and Greiner Bio One.
Tissue culture
Human colon cancer WT (HCT116 WT) cells were obtained
from the European and American Collections of Cell Cultures,
HCT116 SCO2− / − [41] were kindly provided by Professor P.M.
Hwang (Laboratory of Cardiovascular and Cancer Genetics, Na-
tional Heart Lung and Blood Institute, National Institutes of
Health, Bethesda, MD, U.S.A.). Cells were maintained in the Mc-
Coy medium supplemented with 10 % FBS (fetal bovine serum),
2 mM L-glutamine, 100 units/ml penicillin/100 μg/ml strepto-
mycin (P/S) and 10 mM Hepes, pH 7.2. For iO2 and cellular
ATP measurements, WT and SCO2− / − cells were seeded in the
same medium at 1×105 and 8×104 cells per well, respectively, on
96-well plates coated with PDL (poly-D-lysine, 0.01 mg/ml) and
grown for 16 h prior to the experiments. For immunofluorescence
analysis cells were seeded at 1×105 and 8×104 cells per well in
Ibidi 12-well μ-chambers coated with a mixture of collagen IV
(0.007 %) and PDL (0.003 %). For protein and RNA isolation
cells were seeded at 1.1×106 (WT) and 8×105 (SCO2− / − ) cells
per well on 12-well plates (Corning) pre-coated with PDL and
grown for 16 h.
Monitoring of iO2
For the iO2 assay, cells were loaded with NanO2 probe by in-
cubating them in a regular medium containing 10 μg/ml probe
at 37 ◦C for 18–24 h as described [42]. Measurements were con-
ducted at 37 ◦C in serum-free McCoy’s medium buffered with
20 mM Hepes (pH 7.2), typically with 48 samples of adherent
cells in 200 μl of the air-saturated medium (see Supplementary
Figure S1). The cells were treated with Baf and other compounds
for 30 min and then the plate was transferred to a TR-F (time-
resolved fluorescence) plate reader Victor 2 (PerkinElmer Life
Science) placed in a hypoxia chamber (Coy Scientific) equilib-
rated at 6 % atmospheric O2 (∼60 μM dissolved O2). Monitoring
was started using 340 nm excitation and 642 nm emission filters.
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Each sample well was measured repetitively every 5–10 min for
6 h by taking two intensity readings at delay times of 30 and
70 μs, using a gate time of 100 μs [43]. The TR-F intensity
signals were converted into phosphorescence lifetime (τ ) values
as follows: τ = (t1 − t2)/ln(F1/F2), where F1 and F2 are the in-
tensity signals at delay times t1 and t2. The latter were related to
iO2 (μM): [iO2] = 66.72·ln(37.62/(τ–30.24)). From the resulting
iO2 profiles, the rate of cell deoxygenation was calculated as O2
consumed in 1 min by 106 cells (nM/min per 106 cells).
Measurement of the mitochondrial mass and m
(membrane potential), cytosolic Ca2 + and cellular
ATP
Cells were incubated with 50 nM MTG, 20 nM TMRM and
2.5 μM Fluo-4 AM probes in OptiMEM I (supplemented with
an additional 1 mM Ca2 + ) for 30 min in CO2 incubator at 37 ◦C
and then measured. During the measurements, TMRM was main-
tained in OptiMEM at 20 nM. AM probes were de-esterified for
15 min prior to each experiment.
Mitochondrial mass, m and cytosolic Ca2 + were meas-
ured by live cell imaging of MTG, TMRM and Fluo-4 fluores-
cence, respectively, using an Olympus FV1000 confocal laser
scanning microscope with controlled CO2, humidity and temper-
ature. MTG, and Fluo-4 were excited at 488 nm with emission
collected at 500–550 nm. TMRM was excited at 543 nm, emis-
sion was collected with a 555–600 nm filter. In all the experi-
ments, fluorescence and DIC (differential interference contrast)
images were collected in a sequential mode with a ×60 oil im-
mersion objective in a number of planes using 0.5 μm steps. The
resulting z-stacked images were analysed using FV1000 Viewer
(Olympus), Adobe Photoshop and Illustrator software.
Total cellular ATP was quantified using CellTiter-Glo® as-
say following the manufacturer’s protocol. Briefly, the cells were
lysed with CellTiterGlo® reagent and after intensive shaking the
lysates were transferred to white 96-well plates (Greiner Bio
One) and measured on a Victor 2 reader under standard lumin-
escence settings. Conditions of treatment with various effectors
are described in the Results section.
Immunofluorescence
Immunofluorescence analysis was performed similarly to [44].
Briefly, HCT116 cells were seeded on Ibidi chambers, grown and
treated as described above, washed with PBS, fixed with 3.7 %
PFA (paraformaldehyde) in PBS, quenched with 50 mM NH4Cl,
permeabilized with 0.25 % TX100, blocked with 5 % BSA, in-
cubated with anti-HIF-1α (Novus Biologicals) primary and fluor-
escent anti-mouse secondary antibodies conjugated with Alexa
Fluor555 dye (Invitrogen), counterstained with DAPI, mounted
with ProLong® Gold and air-dried. The intensity and localiza-
tion of HIF-1α staining was analysed by confocal microscopy
(Olympus): DIC, DAPI and Alexa-555 images were collected
with a ×60 oil immersion objective in eight planes using a
0.5 μm step in sequential mode using standard excitation and
emission wavelengths. The resulting single plane (DIC) and z-
stacked fluorescent images were analysed using FV1000 Viewer
software (Olympus), Adobe Photoshop and Illustrator.
Protein isolation for Western blot analysis
Whole cell lysate proteins were prepared as described in [33].
Briefly, HCT116 cells grown in the McCoy’s medium on 12-well
plates and treated as described above, were washed twice with
PBS containing phosphatase inhibitors (Active Motif) and lysed
on ice with lysis buffer, containing 150 mM NaCl, 1 mM EDTA,
1 % IGEPAL® CA-630, 50 mM Hepes (pH = 7.5) and protease
inhibitors. After lysate clarification by centrifugation for 10 min
at 14 000 g and 4 ◦C, total protein concentrations were determ-
ined using BCATM Protein Assay kit and normalized. Proteins
were denatured in ×1 Laemmli loading buffer at 95 ◦C and sep-
arated by SDS/PAGE in 10 % and 4–20 % gradient acrylamide
gels, transferred to a 0.2 μm ImmobilonTM-P PVDF membrane
(Sigma) using a HoeferTM TE 22 wet mini-transfer system and
probed with antibodies listed above. The signals were developed
with Amersham ECLTM Prime reagent and visualized on LAS-
3000 Imager (Fujifilm) using Image Reader LAS-3000 2.2 soft-
ware. Quantitative image analysis was performed with ImageJ
program using α-tubulin signals for normalization. Images were
processed with Picasa, Photoshop and Illustrator programs.
Analysis of the HIF-1α HRE (hypoxia response
element)-binding activity
Nuclear and cytosolic protein fractions were prepared from the
cells using Nuclear Extract Kit (Active Motif). The DNA-binding
activity of HIF-1α was analysed using TransAMTM HIF-1 kit
(Active Motif) according to the manufacturer’s protocol. Briefly,
5 μg of proteins were applied on the 96-well plate, pre-coated
with an oligonucleotide containing a HRE (5′-TACGTGCT-3′)
from the EPO (erythropoietin) gene, and incubated for 1 h. With
serial washes after each step, primary mouse anti-HIF-1α and sec-
ondary anti-mouse HRP-conjugated antibodies were sequentially
applied for 1 h. Then signals were developed and absorption was
measured on a TECAN plate reader at 450 nm with a reference
wavelength of 655 nm.
Gene expression analysis by RT–PCR
Total RNA was isolated using an RNA isolation kit (Promega)
as per the manufacturer’s protocol. RT reaction was performed
using ImProm-IITM RT System (Promega) at 42 ◦C for 1 h using
2 μg of total denatured DNA-free RNA in 50 μl reaction mix-
ture containing RT buffer, oligo(dT)15 primers, dNTPs, RNase
inhibitor and reverse transcriptase. After heat inactivation of the
enzyme, standard PCR was performed on Mastercycler (Eppen-
dorf). PCR was carried out at low number of cycles (25–30)
in order to catch a difference in the number of cDNA copies
between the samples. Each reaction was performed in triplicate
in three independent experiments. PCR products were separated
on agarose gels, stained with SafeView probe (NBS Biologicals),
visualized using gel documentation system (Hoefer) and analysed
using ImageJ program.
Statistics
The data were evaluated for statistical difference using two-tailed
Student’s t test. A 0.01 level of confidence was accepted as
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Figure 1 Baf increases respiration in HCT116 cells through mitochondrial uncoupling
(A) The O2 profiles in WT and SCO2− / − HCT116 cells treated with 0.25 μM Baf at 6 % hypoxia. Cells were loaded with
an O2 sensing probe NanO2 and iO2 levels were monitored for 5 h. In control samples respiration was blocked
with AA (10 μM). (B) Treatment with Baf partially depolarizes the mitochondrial membrane potential (m) in WT cells,
as monitored by TMRM staining (20 nM in solution). (C) In SCO2− / − cells the m is reduced, as compared with WT. (D)
A reduction in the m in SCO2− / − cells is not associated with a decrease in the mitochondrial size, as follows from
the comparative analysis of MTG staining and VDAC1 protein levels. Bar represents 20 μm. Asterisks indicate statistical
significance.
statistically significant. Plate reader data are presented as
means +− S.D. for 6–8 repeated wells (error bars shown on the
plots). Imaging data are presented as averages of 5–10 individual
cells. All the experiments were repeated 3–5 times to ensure con-
sistency of results.
RESULTS
Baf induces deep and sustained deoxygenation of
WT HCT116 cells at 6% O2
We reported recently that treatment with Baf induces sustained
mitochondrial uncoupling and reduces iO2 in neuronal cells [33].
Here, to find a link between mitochondrial uncoupling and O2-
dependent signalling, we first analysed the effects of atmospheric
O2 and Baf concentrations on the local deoxygenation of WT and
SCO2− / − HCT116 cells. Using an iO2 sensing probe NanO2
and TR-F plate reader Victor 2 placed in the hypoxic chamber
[43], we found that at 5–8 % atmospheric O2 Baf (0.15–0.35 μM)
induces profound deoxygenation of WT cells (Supplementary
Figure S1 at http://www.bioscirep.org/bsr/032/bsr0320587add.
htm). Thus, treatment with 0.25 μM Baf caused rapid reduction
in iO2, which remained at 0–10 μM levels for several hours (Fig-
ure 1A). Oxygenation of the cells treated with DMSO (mock) or
another V-ATPase inhibitor CMA; results not shown) was sig-
nificantly higher (30–40 μM). The effect of Baf was abolished
by inhibition of the mitochondrial Complex III with AA (anti-
mycin A), which brought iO2 concentration close to the atmo-
spheric levels (∼60 μM). This respiratory response to Baf was
coupled to a partial depolarization of the mitochondria (m),
seen as a decrease in TMRM fluorescence (Figure1B). Similar to
PC12 cells [33], treatment with Baf decreased pH and increased
Ca2 + in the cytoplasm of WT HCT116 (Supplementary Figure
S2 at http://www.bioscirep.org/bsr/032/bsr0320587add.htm). In
contrast, for SCO2− / − cells iO2 profiles were similar to those
in WT cells treated with AA, regardless of the presence of Baf
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Figure 2 Stabilization of HIF-1α and HIF-2α in HCT116 cells upon Baf treatment (0.25 μM) is associated with mitochon-
drial uncoupling
(A) Western blot analysis demonstrates significant elevation in HIF-1α and HIF-2α levels in HCT116 WT cells treated with
Baf for 5 h at 6 % O2. This effect is abolished by inhibiting mitochondrial respiration with AA. In the presence of DMOG,
the level of HIF-1α and HIF-2α stabilization is similar in all samples, including those which are treated with Baf/AA. In the
presence of CMA, HIF-1α and HIF-2α levels in WT cells are also increased significantly, yet to a lesser degree than upon Baf
treatment. (B) Cellular ATP levels are reduced in WT cells treated with Baf/AA for 5 h at 6 % O2, regardless the presence of
DMOG. Treatment with Baf in galactose ( + ) medium causes dramatic decrease in the ATP level. (C) The levels of PHD1,
PHD3, VHL and ATP6V0C proteins are similar in WT and SCO2− / − cells, while the content of PHD2 in SCO2− / − cells
is significantly lower than in WT control. Asterisks indicate statistically significant difference (∗P < 0.01 and ∗∗P < 0.001,
Student’s t test) between the experimental samples and mock control (DMSO). Hash in (A) shows a significant difference
between the effects of Baf and CMA.
(Figure 1A). This result was expected, since SCO2− / − cells de-
ficient in the mitochondrial Complex IV [41] exhibit glycolytic
type ATP production, low OCR (O2 consumption rate) and high
iO2 levels [45].
Live cell imaging and Western blot analysis revealed no differ-
ence in the VDAC1 (voltage-dependent anion channel 1) levels
and MTG fluorescence, demonstrating that relative mitochon-
drial mass in WT and SCO2− / − cells was similar. A decrease in
TMRM staining indicated partial depolarization of the m in
SCO2− / − cells (Figures 1C and 1D). These data confirm that the
decrease in O2 consumption in COX-deficient cells was associ-
ated with mitochondrial respiratory malfunction rather than with
changes in mitochondrial mass.
Baf induces HIF-1α and HIF-2α stabilization through
mitochondrial uncoupling
Activation of the HIF-dependent pathway is a common response
of the cell to the hypoxia. Therefore, we addressed a question
whether the marked decrease in iO2 induced by Baf leads to
stabilization of HIF-1α and HIF-2α at 6 % atmospheric O2. We
found that in WT cells treated with Baf for 5 h the levels of both
HIF-α isoforms were strongly elevated (Figure 2A), as compared
with mock control (DMSO) or low respiring SCO2− / − cells. In-
hibition of mitochondrial respiration with AA abolished HIF-α
stabilization by Baf. ATP levels in the cells treated with Baf/AA
were partially reduced, suggesting that the cells experienced en-
ergy stress (Figure 2B) and could decrease de novo synthesis
of proteins, including HIF-α subunits. To rule out this side ef-
fect, we incubated Baf/AA treated cells with DMOG, which is
known to stabilize HIF-α in an O2-independent manner through
the competitive inhibition of HIF PHDs. We observed that in the
presence of DMOG, HIF-1α and HIF-2α were strongly increased
in all WT cells, regardless of AA treatment and ATP levels (Fig-
ure 2B). This result indicated that the effects of Baf and AA
were attributable to the respiration and iO2 levels. In agreement
with this, stabilization of HIF-1α and HIF-2α in SCO2− / − cells
was observed only in the presence of DMOG. This demonstrates
that synthesis of HIF-1α and HIF-2α in SCO2− / − cells was
preserved.
On the other hand, treatment with CMA also caused signi-
ficant stabilization of HIF-α subunits in WT cells (Figure 2A).
This increase was less pronounced than in the samples treated
with Baf or DMOG, although it proved that HIF-α can also
be stabilized by V-ATPase inhibitors as described [17]. Sur-
prisingly, Baf and CMA had practically no effect on HIF-α
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Figure 3 Nuclear localization and functional activity of HIF-1α in the HCT116 cells treated with Baf at 6 % O2
(A, B) Immunofluorescence analysis shows significant increase in nuclear HIF-1α staining in WT cells treated with Baf
for 5 h. No effect of Baf or CMA on the nuclear HIF-1α accumulation is observed in SCO2− / − cells. Treatment with
DMOG causes translocation of HIF-1 into the nuclei of both WT and SCO2− / − in an O2-independent manner. Nuclei are
counterstained with DAPI. (C) Quantitative analysis of the data shown in (A, B) is performed by measuring HIF-1-specific
fluorescence in the DAPI-positive regions. (D) DNA-binding analysis using TransAM® HIF-1 kit demonstrates an increase in
HIF-1-HRE interaction in WT cells upon Baf treatment. (E) Treatment with Baf activates ‘hypoxia-specific’ gene expression
in WT cells, as demonstrated using RT–PCR analysis. Data are presented as the ratio between mRNA levels in treated
and non-treated cells. (F) Western blot analysis shows that PHD2 protein level is increased in WT cells treated with Baf
and DMOG; however no increase in PHD2 levels in SCO2− / − cells is observed. Asterisks indicate statistically significant
difference between the experimental samples and mock control (DMSO).
stabilization in SCO2− / − cells. According to [17], Baf pro-
motes competition of ATP6V0C with VHL protein for HIF-1α
binding, thus protecting HIF-1α from PHD-dependent degrada-
tion. We hypothesized that stabilization of HIFs in the SCO2− / −
cells did not occur due to a deficiency in ATP6V0C or an in-
crease in VHL or PHD expression. However, Western blot ana-
lysis showed no difference between the two cell lines in the
levels of PHD1, PHD3, ATP6V0C and VHL (Figure 2C), while
PHD2 expression in SCO2− / − cells was even decreased. Un-
der normoxia (20.9 % atmospheric O2), stabilization of HIF-1α
and HIF-2α by Baf or CMA was significantly lower than un-
der anoxia or in the presence of CoCl2 (Supplementary Figure
S3 at http://www.bioscirep.org/bsr/032/bsr0320587add.htm), in
contrast with the effects observed under 6 % O2. Interestingly, in
the cells double-treated with Baf and AA the levels of HIF-1α and
HIF-2α were decreased, which was similar to the effect observed
under hypoxia. This phenomenon was not associated with any
ATP reduction and could be linked to the rate of mitochondrial
respiration.
Baf activates HIF-dependent pathways
HIF proteins trigger adaptation of the cell to hypoxia upon trans-
location to the nucleus where they interact with HRE and modu-
late transcription of the target genes. Using immunofluorescence
analysis, we evaluated the levels of nuclear HIF-1α in WT and
SCO2− / − cells, treated with Baf, CMA, DMOG and DMSO
for 5 h in normoxic and hypoxic conditions. At 6 % atmospheric
O2 we found strong HIF-specific nuclear staining in WT cells
treated with Baf and DMOG, while in SCO2− / − cells nuclear
HIF-1α accumulation was observed only upon DMOG treatment
(Figures 3A–3C). No detectable nuclear staining was observed
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in normoxic samples unless they were incubated with DMOG
(results not shown). To examine functional activity of HIF-1,
we extracted nuclear proteins from the cells treated as above
and performed DNA-binding ELISA analysis using TransAM®
HIF-1 kit. We found that the efficiency of HIF-HRE-binding
correlated with intensity of nuclear HIF-1α staining (Figures 3C
and 3D). This indicates that Baf stabilizes functionally active
HIF-1, which should alter the expression of target genes. To
check this, we examined the effect of Baf on expression of HIF-
dependent genes in hypoxic and normoxic conditions.
At 6 % O2 in WT cells treated with Baf we observed a sig-
nificant increase in mRNA levels for GLUT1 (glucose trans-
porter 1), CAIX (carbonic anhydrase IX) and PHD2, which
were comparable with or higher than those in the DMOG con-
trol (Figure 3E). The level of PHD2 protein was also elevated
(Figure 3F). Treatment with CMA did not affect transcription
of HIF-1 target genes (results not shown). In contrast with
DMOG control, treatment with Baf under normoxia moderately
increased only GLUT1 mRNA level (Supplementary Table S2 at
http://www.bioscirep.org/bsr/032/bsr0320587add.htm). Expres-
sion of HIF-target genes in the resting SCO2− / − cells under
normoxia was practically the same as in WT cells. No changes in
expression of these genes was observed in SCO2− / − cells upon
treatment with Baf, while in the presence of DMOG the levels of
mRNA for GLUT1, CAIX and PHD2 was moderately increased;
gene expression pattern did not change at 6 % O2.
DISCUSSION
In the present study, we describe an activatory effect of moderate
mitochondrial uncoupling on HIF signalling. At moderate hyp-
oxia (6 % atmospheric O2) treatment with the K+ ionophore Baf
activates mitochondrial respiration in colon cancer HCT116 cells
and strongly decreases iO2 (Figure 1A), which is sufficient for
considerable stabilization of HIF-1α and HIF-2α (Figure 2A).
These results are in agreement with the previously shown key
role of mitochondrial respiration in stabilization of HIF-α sub-
units [34–37].
Experiments with Baf and mitochondrial inhibitor AA on two
cell lines exhibiting very different OCR, demonstrate that HIF-α
stabilization is driven by a Baf-dependent increase in mitochon-
drial respiration and cell deoxygenation rather than by other cel-
lular effects of Baf (Figure 2A). The somewhat surprising inhibit-
ory effect of AA on HIF-α stabilization under normoxia (Supple-
mentary Figure S3) is most probably linked to the mitochondrial
activity, and needs further investigation. HIF-α stabilization is not
associated exclusively with mitochondrial uncoupling; treatment
with CMA partially stabilizes HIF-1α and HIF-2α in WT cells,
indicating that the ATP6V0C/VHL-dependent pathway [17] also
contributes to HIF-α stabilization in colon cancer cells. To our
surprise, this pathway seemingly is not active in SCO2− / − cells
(Figure 2A), which exhibit unchanged capacity for HIF-1α and
HIF-2α production (Figure 2A, effect of DMOG). Noteworthy,
Figure 4 Proposed model for Baf-specific stabilization of HIF-α
subunits in an O2-dependent manner
At 20.9 % atmospheric O2 the levels of O2 in the cells treated with Baf
and mock (DMSO) are sufficient for hydroxylation of HIF-1α and HIF-2α,
followed by PHDs-dependent degradation and/or FIH-dependent inhibi-
tion of HIFs. At 5–8 % atmospheric O2 the difference in cell oxygenation
increases; upon treatment with Baf the cells become practically anoxic,
which leads to stabilization of HIF-α subunits (indicated by arrow in in-
set) and activation of HIF pathways. At low atmospheric O2 (0–2 %) the
levels of iO2 are close to zero and HIF signalling is activated regardless
of the presence of Baf.
VHL and ATP6V0C levels in SCO2− / − and WT cells do not
differ (Figure 2C). Moreover, PHD2 levels in SCO2− / − cells are
decreased, while PHD1 and PHD3 remain unchanged, suggesting
a potentially lower rate of HIF-α hydroxylation and degradation.
In WT HCT116 cells treated with Baf under moderate
hypoxia the levels of mRNA for GLUT1, PHD2 and CAIX are
significantly increased (Figure 3E), indicating activation of the
glycolytic proliferative pathway, which disagrees with previous
work [15] in which no significant increase in mRNAs for HIF-1
target genes upon Baf treatment was seen, though their transcrip-
tion was up-regulated by hypoxia. However, this mismatch has a
simple explanation (Figure 4). We performed our experiments at
moderate hypoxia (6 % O2), and the Baf-dependent decrease in
iO2 (by 30–40 μM, as compared with mock control, Figure 1A)
was sufficient for triggering specific gene expression. In the
experimental conditions described in [15], HIF signalling
could be inhibited at high atmospheric O2 by FIH asparaginyl
hydroxylase, while under deep hypoxia (1 % O2) HIF-specific
gene expression was already up-regulated and treatment with
Baf could not increase it any further. In agreement with that,
in spite of HIF-α stabilization in the presence of Baf under
normoxia, we observed no significant elevation of HIF-target
genes, except for a moderate increase in GLUT1 expression
(Supplementary Table S2). The latter, however, most probably
was HIF-independent and resulted from general activation of
glycolysis upon mitochondrial uncoupling by Baf.
Recently it was shown that Baf treatment of PC12 cells is
coupled with a dramatic elevation of free cytosolic Ca2 + due
to Ca2 + release from acidic compartments and partially from
the mitochondria [33]. In hypoxia conditions, cytosolic Ca2 +
overload not only increases the risk of energy crisis, but can
also regulate HIF signalling on transcription, translation and de-
gradation levels (for review see [46]). In the present study, we
observed substantial increases in cytosolic Ca2 + in HCT116 cells
treated with Baf (Supplementary Figure S2). However, we did not
evaluate the putative mediatory role of Ca2 + in Baf-dependent
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stabilization of HIF-1α and HIF-2α, because inhibition of
cellular Ca2 + fluxes decreases respiratory response to Baf and
affects iO2 levels [33].
Mitochondrial uncoupling is implicated in the cell-specific
toxicity of many drugs [47]. This emphasizes the potential im-
portance of the novel Baf-specific HIF-targeting mechanism for
cancer therapy. Moreover, our results indicate that mitochondrial
UCPs (uncoupling proteins), which are often expressed in tu-
mours [48–50], may also be involved in HIF-specific regulation of
cancer cell metabolism. Similar to pharmacological uncouplers,
UCPs accelerate electron flow along the ETC (electron transport
chain), thus elevating respiration. Uncoupling increases local O2
gradients and iO2, and under hypoxia may cause deep deoxy-
genation of the cells [38] and a decrease in tumour growth [51].
One can expect consequent stabilization of HIF-α subunits and
activation of HIF signalling upon UCP up-regulation; however,
to our knowledge no experimental data link together UCPs and
HIF pathways [52]. Establishment of such a link is very attract-
ive, since both UCPs and HIFs are largely involved in cancer
development, including colon cancer [23,53].
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SUPPLEMENTARY ONLINE DATA
Bafilomycin A1 activates HIF-dependent signalling
in human colon cancer cells via mitochondrial
uncoupling
Alexander V. ZHDANOV1, Ruslan I. DMITRIEV and Dmitri B. PAPKOVSKY
Biochemistry Department, University College Cork, Cork, Ireland
Figure S1 Baf increases cellular respiration in a concentration-
dependent manner
Experiment was conducted in a hypoxia chamber at 6 % atmospheric
O2. Asterisk indicates significant difference.
1 To whom correspondence should be addressed (email a.zhdanov@ucc.ie).
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Figure S2 Treatment with Baf induces 3.5-fold increase in Fluo-4
intensity, reflecting strong elevation of cytosolic Ca2 +
Live cell confocal images of the cells treated with 0.25 μM Baf or mock
(DMSO) for 1.5 h, z-stack of two planes. Bar represents 20 μm.
Figure S3 Baf-dependent stabilization of HIF-α in normoxia is substantially lower than in anoxia or on treatment with
CoCl2
Effects of Baf and CMA are similar. Inset, ratio between HIF levels upon treatment with Baf (0.25 μM) and CoCl2 (200 μM)
is shown.
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Uncoupling with bafilomycin activates HIF signalling in cancer cells
Table S1 Primers used for analysis of gene expression by RT-PCR
ATCB, β -actin; LDHA, lactate dehydrogenase.
Genes Forward primer Reverse primer
VEGFA 5′ -GTGTGCGCAGACAGTGCTCCAG-3′ 5′ -AGGAAGCTCATCTCTCCTATGTGCTG-3′
GLUT-1 5′ -CAGCAGCCTGTGTATGCCACCA-3′ 5′ -AAGCCGGAAGCGATCTCATCGA-3′
LDHA 5′ -GTGCCATCAGTATCTTAATGAAGGACTTG-3′ 5′ -TCCAAGCCACGTAGGTCAAGATATCC-3′
ATCB 5′ -GAGCGGGAAATCGTGCGTGACA-3′ 5′ -GTACATGGTGGTGCCGCCAGAC-3′
CAIX 5′ -GGCGAGGAGGATCTGCCCA-3′ 5′ -GTGGCCATTGTTGCGCAGGC-3′
PHD2 5′ - CAAGCTCGTGTGCCAGGGCA-3′ 5′ - GCCCGTCCGTGAACTTCCCG-3′
PHD3 5′ - CTGGAGCGCGTCAAGCAGCT-3′ 5′ - TTGGGGTTGTCCACGTGGCG-3′
PDK1 5′ -TGCGGCAAGAGTTGCCTGTCAG-3′ 5′ -GCTGGTGACAGGATCCACCCCA-3′
Table S2 Gene expression levels in HCT116 cells, WT (at 20.9 % O2) and SCO2− / − (at 6 and 20.9 % O2)
Results are normalized to mock control (WT cells treated with DMSO). LDHA, lactate dehydrogenase.
Cell type Atmospheric O2 level Treatment Genes
GLUT1 LDHA CAIX PHD2
SCO2− / − 20.9% DMSO 1 +− 0.1 0.9 +− 0.2 0.6 +− 0.3 1.1 +− 0.3
Baf 1.1 +− 0.2 1.1 +− 0.2 0.8 +− 0.2 1.1 +− 0.2
DMOG 1.6 +− 0.3 1.2 +− 0.1 1.3 +− 0.6 1.4 +− 0.1
6% DMSO 1.1 +− 0.2 1 +− 0.2 0.9 +− 0.2 0.8 +− 0.1
Baf 1.1 +− 0.2 1.1 +− 0.2 1.1 +− 0.1 1 +− 0.1
DMOG 1.6 +− 0.2 1.3 +− 0.3 1.4 +− 0.2 1.6 +− 0.2
WT 20.9% DMSO 1 +− 0.1 1 +− 0.1 1 +− 0.1 1 +− 0.1
Baf 1.3 +− 0.2 1 +− 0.1 1.2 +− 0.2 1.1 +− 0.1
DMOG 1.7 +− 0.2 1.5 +− 0.2 1.9 +− 0.2 2.2 +− 0.1
Received 31 July 2012; accepted 1 August 2012
Published as Immediate Publication 3 September 2012, doi 10.1042/BSR20120085
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
C© 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/







ent user on 10 M
arch 2021
